EmbA

EmbA, short for arabinosyl transferase A, is a component of the EmbCAB enzyme complex found in many mycobacteria and related actinomycetes. It is a membrane-associated glycosyltransferase involved in arabinan biosynthesis as part of the cell wall arabinogalactan.

EmbA catalyzes the transfer of arabinose units from the donor molecule decaprenylphosphoryl-D-arabinose (DPA) to growing arabinan chains attached to the galactan backbone of arabinogalactan. The arabinan moiety is linked to the mycolic acid–containing layer, forming the cell wall architecture that is essential for permeability barrier and viability in mycobacteria.

Genetically, embA is encoded by the embA gene (Rv3790 in Mycobacterium tuberculosis H37Rv) and is commonly located in an operon with embB and embC. The EmbA protein is predicted to be an integral inner membrane protein with multiple transmembrane segments, consistent with a membrane-located glycosyltransferase that acts on lipid-linked sugar donors at the cytoplasmic membrane.

Clinically and pharmacologically, EmbA is a target of ethambutol, a first-line antitubercular drug that inhibits arabinosyl transferases of the EmbCAB complex, thereby disrupting arabinan synthesis and cell wall assembly. Mutations in embA or altered regulation can contribute to ethambutol susceptibility or resistance, though embB mutations are more commonly associated with resistance. EmbA’s essential role in arabinan biosynthesis makes it a focus of ongoing research for new therapeutic inhibitors.